Stocks TelegraphStocks Telegraph
Stock Ideas

CRVO Financial Statements and Analysis

NASDAQ : CRVO

CervoMed

$8.04
0.44+5.79%
Open: 2:57 PM

FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

DateSep 30, 2025Jun 30, 2025Mar 31, 2025Sep 30, 2024Jun 30, 2024
reported currencyUSDUSDUSDUSDUSD
calendar year20252025202520242024
periodQ3Q2Q1Q3Q2
revenue322.569K0003.289M
cost of revenue00000
gross profit322.569K0003.289M
gross profit ratio1.000001.00
research and development expenses6.04M5.109M4.838M5.125M3.772M
general and administrative expenses2.326M3.265M2.383M2.211M2.512M
selling and marketing expenses00000
selling general and administrative expenses2.326M3.265M2.383M2.211M2.512M
other expenses0-1.758M-1.917M-1.94M0
operating expenses8.367M6.616M5.303M5.396M6.284M
cost and expenses8.367M6.616M5.303M5.396M6.284M
interest income318.787K368.127K408.985K646.172K678.441K
interest expense00000
depreciation and amortization-1.000000
ebitda-7.727M-6.616M-5.303M-5.396M-2.995M
ebitda ratio-23.953000-0.911
operating income-8.044M-6.616M-5.303M-5.396M-2.995M
operating income ratio-24.938000-0.911
total other income expenses net317.56K357.871K408.85K642.732K678.194K
income before tax-7.727M-6.258M-4.894M-4.754M-2.317M
income before tax ratio-23.953000-0.704
income tax expense00000
net income-7.727M-6.258M-4.894M-4.754M-2.317M
net income ratio-23.953000-0.704
eps-0.84-0.70-0.56-0.55-0.27
eps diluted-0.84-0.70-0.56-0.55-0.27
weighted average shs out9.253M8.951M8.703M8.703M8.703M
weighted average shs out dil9.253M8.951M8.703M8.703M8.703M
Graph

Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

DateSep 30, 2025Jun 30, 2025Mar 31, 2025Sep 30, 2024Jun 30, 2024
reported currencyUSDUSDUSDUSDUSD
calendar year20252025202520242024
periodQ3Q2Q1Q3Q2
cash and cash equivalents9.437M8.321M10.502M7.744M10.009M
short term investments17.857M25.21M24.743M38.913M35.083M
cash and short term investments27.294M33.531M35.245M46.657M45.092M
net receivables1.361M2.361M1.629M264.148K0
inventory00000
other current assets1.955M2.189M1.704M1.889M2.236M
total current assets30.611M38.081M38.577M48.81M47.328M
property plant equipment net00000
goodwill00000
intangible assets00000
goodwill and intangible assets00000
long term investments00005.806M
tax assets00000
other non current assets00073.937K56.234K
total non current assets00073.937K5.862M
other assets00000
total assets30.611M38.081M38.577M48.884M53.191M
account payables1.349M1.846M1.861M1.082M725.854K
short term debt00000
tax payables0058.98K30.456K20.456K
deferred revenue00001.402M
other current liabilities3.25M02.023M2.133M1.066M
total current liabilities4.599M1.846M3.943M3.246M3.214M
long term debt00000
deferred revenue non current00000
deferred tax liabilities non current00000
other non current liabilities02.796M02.164M0
total non current liabilities02.796M02.164M0
other liabilities000-2.164M0
capital lease obligations00000
total liabilities4.599M4.642M3.943M3.246M3.214M
preferred stock00000
common stock9.252K9.252K8.702K8.253K8.253K
retained earnings-89.611M-81.884M-75.626M-64.026M-59.272M
accumulated other comprehensive income loss5.824K-783.0021.223K123.162K-19.702K
other total stockholders equity115.607M115.315M110.23M109.532M109.26M
total stockholders equity26.011M33.44M34.634M45.637M49.977M
total equity26.011M33.44M34.634M45.637M49.977M
total liabilities and stockholders equity30.611M38.081M38.577M48.884M53.191M
minority interest00000
total investments17.857M25.21M24.743M38.913M40.889M
total debt00000
net debt-9.437M-8.321M-10.502M-7.744M-10.009M
Graph

Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

DateSep 30, 2025Jun 30, 2025Mar 31, 2025Jun 30, 2024Mar 31, 2024
reported currencyUSDUSDUSDUSDUSD
calendar year20252025202520242024
periodQ3Q2Q1Q2Q1
deferred income tax00000
stock based compensation00361.167K578.581K218.215K
change in working capital1.463M-518.64K890.336K-125.113K872.446K
accounts receivables0-731.748K625.004K0915.404K
inventory00000
accounts payables0-76.566K349.158K293.786K-230.403K
other working capital1.463M289.674K-83.826K-418.899K187.445K
other non cash items-201.267K262.349K-251.828K-53.413K-466.786K
net cash provided by operating activities-6.465M-6.515M-3.894M-2.202M-1.424M
investments in property plant and equipment0005.000
acquisitions net00000
purchases of investments0-9.755M-7.103M-40.57M0
sales maturities of investments09.50M12.50M00
other investing activites7.582M00-40.57M0
net cash used for investing activites7.582M-254.993K5.397M-40.57M0
debt repayment00000
common stock issued04.589M046.412M0
common stock repurchased00000
dividends paid00000
other financing activites00046.412M0
net cash used provided by financing activities04.589M046.412M0
effect of forex changes on cash00000
net change in cash1.117M-2.181M1.502M3.64M-1.424M
cash at end of period9.437M8.321M10.502M10.009M6.369M
cash at beginning of period8.321M10.502M8.999M6.369M7.793M
operating cashflow-6.465M-6.515M-3.894M-2.202M-1.424M
capital expenditure0-5.0005.000
free cash flow-6.465M-6.515M-3.894M-2.202M-1.424M
Graph

Frequently Asked Questions

How did CervoMed Inc. do last quarter? What was its Total Revenue and Cost of Revenue?
A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, CRVO generated $322.57K in revenue last quarter, while its costs came in at $0.00.
Last quarter, how much Gross Profit did CervoMed Inc. report?
A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. CervoMed Inc. reported a $322.57K Gross Profit for the quarter ended Sep 30, 2025.
Have CRVO's Total Operating Expenses and Operating Income been favorable recently?
Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. CRVO incurred $8.37M worth of Operating Expenses, while it generated -$8.04M worth of Operating Income.
How much Net Income has CRVO posted recently?
The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from CervoMed Inc., the company generated -$7.73M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.
At the end of the last quarter, how much Cash and Equivalents did CervoMed Inc. have?
The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to CervoMed Inc. as of the end of the last quarter was $9.44M.
What are CRVO's Total Net Receivables for the last quarter?
Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, CRVO had Total Net Receivables of $1.36M.
In terms of Total Assets and Current Assets, where did CervoMed Inc. stand at?
An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of CRVO were $30.61M, while the Total Assets stand at $30.61M.
As of the last quarter, how much Total Debt did CervoMed Inc. have?
The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of CRVO's debt was $0.00 at the end of the last quarter.
What were CRVO's Total Liabilities during the last reported quarter?
A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, CRVO reported total liabilities of $4.60M.
How much did CRVO's Working Capital change over the last quarter?
Working Capital Change for CRVO was $1.46M over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.
CRVO generated how much cash from operating activities?
An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. CRVO generated -$6.47M of Cash from Operating Activities during its recently reported quarter.
What was CRVO's latest reported Net Change in Cash?
An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. CRVO reported a $1.12M Net Change in Cash in the most recent quarter.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph